SciELO - Scientific Electronic Library Online

 
vol.25 issue2Internal validity and reliability of the CAGE test in Bucaramanga, ColombiaSpecific expression of inflammatory genes in macrophage subpopulations author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Biomédica

Print version ISSN 0120-4157On-line version ISSN 2590-7379

Abstract

OSORIO, Edison J; ROBLEDO, Sara M; ARANGO, Gabriel J  and  MUSKUS, Carlos E. Leishmania: role of P glycoprotein in drug resistance and reversion strategies. Biomédica [online]. 2005, vol.25, n.2, pp.242-260. ISSN 0120-4157.

Protozoan parasites are important causative agents of morbidity and mortality throughout the world -a problem further complicated by the emergence of drug resistance in these parasites. Mechanisms of drug resistance include the following: decreased uptake of the drug into the cell, loss of drug activation, alterations in the drug target, and over-expression of a well-known multiple drug transporter proteins. In this review, two critical components of resistance are stressed: (1) the role of ATP binding cassette proteins, such as P-glycoproteins, in mediating drug resistance in Leishmania and other protozoans, followed by development of cross-resistance to many structurally and functionally unrelated drugs, and (2) some concepts concerning the reversal mechanism of multidrug resistance by drugs and natural products. Several modulators or chemosensitizers alter the capacity of P-glycoproteins to maintain subtoxic intracellular drug concentrations. Calcium channel blockers such as verapamil act in this mode; however, high concentrations are required for an efficient and effective inhibition and, in addition, produce undesirable side effects. The discovery of new, natural product modulators of P-glycoproteins is stressed. This category of modulators offer potentially improved efficacy and lowered toxicity for the mammalian host.

Keywords : Protozoa; Leishmania; multidrug resistance; P-glycoprotein; natural products.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License